Skip to main content
TipRanks
Go Ultimate75% OFF

Xspray Pharma AB (XSPRAY) Income Statement

3 Followers

Xspray Pharma AB Income Statement

Last quarter (Q3 2026), Xspray Pharma AB's total revenue was kr0.00. In Q3, Xspray Pharma AB's net income was kr-39.31M. See Xspray Pharma AB’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
kr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
kr -5.58Mkr -8.55Mkr -9.19Mkr -9.53Mkr -8.87M
kr 156.27Mkr 287.04Mkr 181.73Mkr 131.38Mkr 96.95M
Depreciation and Amortizationkr 5.58Mkr 8.55Mkr 9.19Mkr 9.53Mkr 8.87M
kr -156.27Mkr -274.69Mkr -169.81Mkr -122.13Mkr -87.82M
kr -161.85Mkr -283.24Mkr -181.73Mkr -133.07Mkr -97.95M
kr -9.69Mkr -2.44Mkr 2.05Mkr 1.40Mkr 1.25M
kr -171.55Mkr -285.67Mkr -179.68Mkr -131.67Mkr -96.70M
kr -171.44Mkr -285.52Mkr -179.67Mkr -130.27Mkr -96.70M
Per Share Metrics
Basic EPSkr -4.46kr -8.62kr -6.76kr -6.13kr -4.98
Diluted EPSkr -4.46kr -8.62kr -6.76kr -6.13kr -4.98
Weighted Average Shares Outstanding38.45M33.12M26.58M21.26M19.41M
Weighted Average Shares Outstanding (Diluted)38.45M33.14M26.59M21.26M19.41M

Currency in SEK

Xspray Pharma AB Earnings and Revenue History

-300M-150M0150M-10000 %-7500 %-5000 %-2500 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin